Cargando…
Ulcerative intestinal tuberculosis case as a complication of treatment by infliximab for intestinal Behçet's disease: A case report
RATIONALE: Intestinal Behçet's disease (BD) is characterized by intestinal ulcerations and gastrointestinal symptoms. Ulcerative intestinal tuberculosis (TB) is usually with dyspepsia, abdominal pain, vomiting, and weight loss. The 2 diseases exhibit similar clinical manifestations, but the mos...
Autores principales: | Shen, Yan, Ma, Hai-fen, Yang, Yan-li, Guan, Jian-long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824802/ https://www.ncbi.nlm.nih.gov/pubmed/31651888 http://dx.doi.org/10.1097/MD.0000000000017652 |
Ejemplares similares
-
Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report
por: Chen, Yong, et al.
Publicado: (2017) -
Behçet's Disease Complicated with Thrombosis: A Report of 93 Chinese Cases
por: Wu, Xiuhua, et al.
Publicado: (2014) -
Successful mesenchymal stem cell treatment of leg ulcers complicated by Behcet disease: A case report and literature review
por: Li, Yanhong, et al.
Publicado: (2018) -
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study
por: Hibi, Toshifumi, et al.
Publicado: (2016) -
Intestinal Behçet disease associated with myelodysplastic syndrome accompanying trisomy 8 successfully treated with abdominal surgery followed by hematopoietic stem cell transplantation: A case report
por: Asano, Tomoyuki, et al.
Publicado: (2019)